BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31997369)

  • 21. A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain.
    de Jong M; Peeters F; Gard T; Ashih H; Doorley J; Walker R; Rhoades L; Kulich RJ; Kueppenbender KD; Alpert JE; Hoge EA; Britton WB; Lazar SW; Fava M; Mischoulon D
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 28252881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
    Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
    BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients.
    Assmann N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
    Depress Anxiety; 2018 Oct; 35(10):1001-1008. PubMed ID: 30199128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pilot Randomized Controlled Trial Comparing Mindfulness Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Chronic Low Back Pain.
    Day MA; Ward LC; Ehde DM; Thorn BE; Burns J; Barnier A; Mattingley JB; Jensen MP
    Pain Med; 2019 Nov; 20(11):2134-2148. PubMed ID: 30605517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder.
    Kim YW; Lee SH; Choi TK; Suh SY; Kim B; Kim CM; Cho SJ; Kim MJ; Yook K; Ryu M; Song SK; Yook KH
    Depress Anxiety; 2009; 26(7):601-6. PubMed ID: 19242985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.
    Jobst A; Sabaß L; Hall D; Brücklmeier B; Buchheim A; Hall J; Sarubin N; Zill P; Falkai P; Brakemeier EL; Padberg F
    J Affect Disord; 2018 Feb; 227():206-213. PubMed ID: 29100154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
    Thase ME; Rush AJ; Manber R; Kornstein SG; Klein DN; Markowitz JC; Ninan PT; Friedman ES; Dunner DL; Schatzberg AF; Borian FE; Trivedi MH; Keller MB
    J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.
    Bausch P; Fangmeier T; Zobel I; Schoepf D; Drost S; Schnell K; Walter H; Berger M; Normann C; Schramm E
    Clin Psychol Psychother; 2017 Sep; 24(5):1155-1162. PubMed ID: 28326653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive reactivity as outcome and working mechanism of mindfulness-based cognitive therapy for recurrently depressed patients in remission.
    Cladder-Micus MB; van Aalderen J; Donders ART; Spijker J; Vrijsen JN; Speckens AEM
    Cogn Emot; 2018 Mar; 32(2):371-378. PubMed ID: 28278742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
    Schramm E; Kriston L; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Bausch P; Fangmeier T; Meister R; Berger M; Hautzinger M; Härter M
    JAMA Psychiatry; 2017 Mar; 74(3):233-242. PubMed ID: 28146251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression.
    Cladder-Micus MB; Vrijsen JN; Fest A; Spijker J; Donders ART; Becker ES; Speckens AEM
    J Affect Disord; 2023 Aug; 335():410-417. PubMed ID: 37178825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression.
    Schramm E; Kriston L; Elsaesser M; Fangmeier T; Meister R; Bausch P; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Löwe B; Walter H; Wolf M; Domschke K; Berger M; Hautzinger M; Härter M
    Psychother Psychosom; 2019; 88(3):154-164. PubMed ID: 31121581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of group mindfulness-based cognitive therapy and group cognitive behavioural therapy on symptomatic generalized anxiety disorder: a randomized controlled noninferiority trial.
    Jiang SS; Liu XH; Han N; Zhang HJ; Xie WX; Xie ZJ; Lu XY; Zhou XZ; Zhao YQ; Duan AD; Zhao SQ; Zhang ZC; Huang XB
    BMC Psychiatry; 2022 Jul; 22(1):481. PubMed ID: 35854250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
    Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA; Markowitz JC; Thase ME;
    Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time trends in the effects of mindfulness-based cognitive therapy for depression: A meta-analysis.
    Thimm JC; Johnsen TJ
    Scand J Psychol; 2020 Aug; 61(4):582-591. PubMed ID: 32319124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial.
    Tovote KA; Fleer J; Snippe E; Peeters AC; Emmelkamp PM; Sanderman R; Links TP; Schroevers MJ
    Diabetes Care; 2014 Sep; 37(9):2427-34. PubMed ID: 24898301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added value of Mindfulness-Based Cognitive Therapy for Depression: A Tree-based Qualitative Interaction Analysis.
    Ter Avest MJ; Dusseldorp E; Huijbers MJ; van Aalderen JR; Cladder-Micus MB; Spinhoven P; Greven CU; Speckens AEM
    Behav Res Ther; 2019 Nov; 122():103467. PubMed ID: 31557693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depression.
    Constantino MJ; Laws HB; Arnow BA; Klein DN; Rothbaum BO; Manber R
    J Consult Clin Psychol; 2012 Jun; 80(3):354-64. PubMed ID: 22545738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.